These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12543655

  • 1. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Weiss WJ, Edelstein MA.
    Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Shinzato T, Doyle E, Edelstein MA.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [Abstract] [Full Text] [Related]

  • 3. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH, Shinzato T, Edelstein MA.
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Lehr KH, Ren J.
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Higa F, Edelstein MA.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Holzknecht B.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Weidenfeld J, Dorr MB.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [Abstract] [Full Text] [Related]

  • 9. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Ren J, Polzer R, Gladue RP.
    Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F, Arakaki N, Tateyama M, Koide M, Shinzato T, Kawakami K, Saito A.
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [Abstract] [Full Text] [Related]

  • 11. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
    Stamler DA, Edelstein MA, Edelstein PH.
    Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446
    [Abstract] [Full Text] [Related]

  • 12. Review of azithromycin activity against Legionella spp.
    Edelstein PH.
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.
    Smith GM, Abbott KH, Sutherland R.
    J Antimicrob Chemother; 1992 Oct; 30(4):525-34. PubMed ID: 1490922
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of macrolides against intracellular Legionella pneumophila.
    Segreti J, Meyer P, Kapell K.
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of tetracyclines on experimental Legionella pneumophila infection in guinea-pigs.
    Yoshida S, Mizuguchi Y, Ohta H, Ogawa M.
    J Antimicrob Chemother; 1985 Aug; 16(2):199-204. PubMed ID: 4066557
    [Abstract] [Full Text] [Related]

  • 18. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH, Hu B, Edelstein MA.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [Abstract] [Full Text] [Related]

  • 19. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs.
    Saito A, Koga H, Shigeno H, Watanabe K, Mori K, Kohno S, Shigeno Y, Suzuyama Y, Yamaguchi K, Hirota M.
    J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol.
    Fitzgeorge RB, Featherstone AS, Baskerville A.
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():101-8. PubMed ID: 2154427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.